Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder

Propranolol, a non-cardioselective β<sub>1,2</sub> blocker, is most commonly recognised for its application in the therapy of various cardiovascular conditions, such as hypertension, coronary artery disease, and tachyarrhythmias. However, due to its ability to cross the blood–brain barri...

Full description

Bibliographic Details
Main Authors: Łukasz Szeleszczuk, Dawid Frączkowski
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/17/10099
_version_ 1797494950831587328
author Łukasz Szeleszczuk
Dawid Frączkowski
author_facet Łukasz Szeleszczuk
Dawid Frączkowski
author_sort Łukasz Szeleszczuk
collection DOAJ
description Propranolol, a non-cardioselective β<sub>1,2</sub> blocker, is most commonly recognised for its application in the therapy of various cardiovascular conditions, such as hypertension, coronary artery disease, and tachyarrhythmias. However, due to its ability to cross the blood–brain barrier and affinity towards multiple macromolecules, not only adrenoreceptors, it has also found application in other fields. For example, it is one of the very few medications successfully applied in the treatment of stage fright. This review focuses on the application of propranolol in the treatment of various types of anxiety and stress, with particular reference to stage fright and post-traumatic stress disorder (PTSD). Both mechanisms of action as well as comparison with other therapies are presented. As those indications for propranolol are, in most countries, considered off-label, this review aims to gather information that can be useful while making a decision about the choice of propranolol as a drug in the treatment of those mental conditions.
first_indexed 2024-03-10T01:41:36Z
format Article
id doaj.art-a4c9707de1d94f8e9a1c4312a3a35509
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T01:41:36Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a4c9707de1d94f8e9a1c4312a3a355092023-11-23T13:22:51ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-09-0123171009910.3390/ijms231710099Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress DisorderŁukasz Szeleszczuk0Dawid Frączkowski1Department of Physical Chemistry, Chair and Department of Physical Pharmacy and Bioanalysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-093 Warsaw, PolandDepartment of Physical Chemistry, Chair and Department of Physical Pharmacy and Bioanalysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-093 Warsaw, PolandPropranolol, a non-cardioselective β<sub>1,2</sub> blocker, is most commonly recognised for its application in the therapy of various cardiovascular conditions, such as hypertension, coronary artery disease, and tachyarrhythmias. However, due to its ability to cross the blood–brain barrier and affinity towards multiple macromolecules, not only adrenoreceptors, it has also found application in other fields. For example, it is one of the very few medications successfully applied in the treatment of stage fright. This review focuses on the application of propranolol in the treatment of various types of anxiety and stress, with particular reference to stage fright and post-traumatic stress disorder (PTSD). Both mechanisms of action as well as comparison with other therapies are presented. As those indications for propranolol are, in most countries, considered off-label, this review aims to gather information that can be useful while making a decision about the choice of propranolol as a drug in the treatment of those mental conditions.https://www.mdpi.com/1422-0067/23/17/10099propranololanxietystage frightPTSDpost-traumatic stress disorder
spellingShingle Łukasz Szeleszczuk
Dawid Frączkowski
Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder
International Journal of Molecular Sciences
propranolol
anxiety
stage fright
PTSD
post-traumatic stress disorder
title Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder
title_full Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder
title_fullStr Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder
title_full_unstemmed Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder
title_short Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder
title_sort propranolol versus other selected drugs in the treatment of various types of anxiety or stress with particular reference to stage fright and post traumatic stress disorder
topic propranolol
anxiety
stage fright
PTSD
post-traumatic stress disorder
url https://www.mdpi.com/1422-0067/23/17/10099
work_keys_str_mv AT łukaszszeleszczuk propranololversusotherselecteddrugsinthetreatmentofvarioustypesofanxietyorstresswithparticularreferencetostagefrightandposttraumaticstressdisorder
AT dawidfraczkowski propranololversusotherselecteddrugsinthetreatmentofvarioustypesofanxietyorstresswithparticularreferencetostagefrightandposttraumaticstressdisorder